Prostate cancer cells with CDKL3 knockdown exhibited weakened proliferative activity, enhanced apoptosis, and decreased motility, while xenografts formed by CDKL3 knockdown cells showed distinctly slower growth rates than that formed by control cells. This evidence concerns the gene CDKL3 and prostate carcinoma.